GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: VG3927
Compound class:
Synthetic organic
Comment: VG-3927 (Vigil Neuroscience) is an orally available TREM2 agonist [2]. It is proposed to increase the neuroprotective functions of microglia, as a mechanism to combat Alzheimer's disease-driven brain pathologies.
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Mirescu C. (2025)
Characterization of the first TREM2 small molecule agonist, VG‐3927, for clinical development in Alzheimer’s disease. Alzheimers Dement, 20 (Suppl 6): e084622. DOI: 10.1002/alz.084622 |
|
2. Yuan S, El Gaamouch F, Cho S, Kuncewicz K, Nada H, Gabr MT. (2025)
Discovery of a Small Molecule TREM2 Agonist with Improved In Vitro Pharmacokinetic Profile and Validated Target Engagement. ACS Med Chem Lett, 16 (8): 1634-1640. [PMID:40832531] |